Pharmabiz58m
Pharming gets UK MHRA marketing authorization for Joenja to treat activated phosphoinositide 3-kinase delta (PI3Kd) syndrome
Leiden, the Netherlands Saturday, September 28, 2024, 10:00 Hrs [IST] ...
Pharmabiz35m
Pharma associations in TN to organise interactive meeting with regulatory officers prior to preliminary inspections
Giving full support to the endeavours being initiated by the regulatory department of Tamil Nadu in implementing the Revised Schedule M in the pharma sector, the pharmaceutical industry in the state ...
Pharmabiz35m
CDSCO declares 59 drugs tested in August as Not of Standard Quality
The Central Drugs Standard Control Organisation (CDSCO) has released a list of 59 drug samples declared as Not of Standard Quality (NSQ) during the month of August, with samples of drugs labelled as ...
Pharmabiz2h
Karnataka govt to strengthen security measures across hospitals in 31 districts after Kolkata incident
Karnataka govt to strengthen security measures across hospitals in 31 districts after Kolkata incident: Nandita Vijayasimha, Bengaluru Saturday, September 28, 2024, 08:00 Hrs [IST ...
Pharmabiz2h
Pain management making a paradigm shift towards drug free regimes: Dr Apoorva Shrivastava
Pain management making a paradigm shift towards drug free regimes: Dr Apoorva Shrivastava: Nandita Vijayasimha, Bengaluru Saturday, September 28, 2024, 08:00 Hrs [IST] Pain manage ...
Pharmabiz2h
Jan Aushadhi Kendras report 6.7 per cent growth in sales in August
Jan Aushadhi Kendras report 6.7 per cent growth in sales in August: Gireesh Babu, New Delhi Saturday, September 28, 2024, 08:00 Hrs [IST] The Jan Aushadhi Kendras (JAKs) under the ...
Pharmabiz1h
US FDA approves Bristol-Myers Squibb’s antipsychotic drug, Cobenfy for treatment of schizophrenia
US FDA approves Bristol-Myers Squibb’s antipsychotic drug, Cobenfy for treatment of schizophrenia: Maryland Saturday, September 28, 2024, 09:00 Hrs [IST] The US Food and Drug Ad ...
Pharmabiz18h
Bristol Myers Squibb, 2seventy bio to discontinue enrollment in phase 3 KarMMa-9 study of Abecma in patients with newly diagnosed MM
Bristol Myers Squibb, 2seventy bio to discontinue enrollment in phase 3 KarMMa-9 study of Abecma in patients with newly diagnosed MM: Princeton, New Jersey Friday, September 27, 2 ...
Pharmabiz1d
D&C violations galore in Hyderabad, DCA officials crackdown on unlicensed pharmacy and quack’s premises
Peethaambaran Kunnathoor, Chennai Friday, September 27, 2024, 08:00 Hrs [IST] ...
Pharmabiz18h
Celnova Pharma to distribute Lupin’s orphan drug, NaMuscla in Argentina & Colombia to treat myotonia in adults with NDM disorders
Our Bureau, Mumbai Friday, September 27, 2024, 16:15 Hrs [IST] ...
Pharmabiz1d
Responsibilities of pharmacists expanded beyond merely dispensing medicines: Union health minister
Responsibilities of pharmacists expanded beyond merely dispensing medicines: Union health minister: Our Bureau, New Delhi Friday, September 27, 2024, 08:00 Hrs [IST] The responsib ...
Pharmabiz1d
DoP modifies successor-in-interest clause of PLI scheme for bulk drugs
DoP modifies successor-in-interest clause of PLI scheme for bulk drugs: Gireesh Babu, New Delhi Friday, September 27, 2024, 08:00 Hrs [IST] The Department of Pharmaceuticals (DoP) ...